5 Value Stocks To Watch In The Healthcare Sector

What are Value Stocks?

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

The following stocks are considered to be notable value stocks in the healthcare sector:

1. Pfizer (NYSE:PFE) - P/E: 7.46
2. Fulgent Genetics (NASDAQ:FLGT) - P/E: 6.74
3. Maravai LifeSciences (NASDAQ:MRVI) - P/E: 8.39
4. ProPhase Labs (NASDAQ:PRPH) - P/E: 7.48
5. Zymeworks (NASDAQ:ZYME) - P/E: 4.76

This quarter, Pfizer experienced a decrease in earnings per share, which was $1.78 in Q3 and is now $1.14. Its most recent dividend yield is at 3.17%, which has decreased by 0.47% from 3.64% in the previous quarter.

Fulgent Genetics saw a decrease in earnings per share from 0.32 in Q3 to $-0.48 now. Maravai LifeSciences has reported Q4 earnings per share at $0.35, which has decreased by 5.41% compared to Q3, which was 0.37. ProPhase Labs's earnings per share for Q4 sits at $-0.08, whereas in Q3, they were at 0.06. Zymeworks's earnings per share for Q4 sits at $4.71, whereas in Q3, they were at -0.66.

These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.